| Literature DB >> 27886210 |
Tariq I Almundarij1,2, Mark E Smyers3, Addison Spriggs2, Lydia A Heemstra2, Lisa Beltz4, Eric Dyne3,5, Caitlyn Ridenour4, Colleen M Novak2,3.
Abstract
Melanocortin 4 receptor (MC4R) variants contribute to human obesity, and rats lacking functional MC4R (Mc4rK314X/K314X) are obese. We investigated the hypothesis that low energy expenditure (EE) and physical activity contribute to this obese phenotype in male rats, and determined whether lack of functional MC4R conferred protection from weight loss during 50% calorie restriction. Though Mc4rK314X/K314X rats showed low brown adipose Ucp1 expression and were less physically active than rats heterozygous for the mutation (Mc4r+/K314X) or wild-type (Mc4r+/+) rats, we found no evidence of lowered EE in Mc4rK314X/K314X rats once body weight was taken into account using covariance. Mc4rK314X/K314X rats had a significantly higher respiratory exchange ratio. Compared to Mc4r+/+ rats, Mc4rK314X/K314X and Mc4r+/K314X rats lost less lean mass during calorie restriction, and less body mass when baseline weight was accounted for. Limited regional overexpression of Mc3r was found in the hypothalamus. Although lower physical activity levels in rats with nonfunctional MC4R did not result in lower total EE during free-fed conditions, rats lacking one or two functional copies of Mc4r showed conservation of mass, particularly lean mass, during energy restriction. This suggests that variants affecting MC4R function may contribute to individual differences in the metabolic response to food restriction.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27886210 PMCID: PMC5122857 DOI: 10.1038/srep37435
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Body composition and calorimetry measures from measurement of 24-hr energy expenditure (EE), and activity-EE (treadmill test); Mean (SEM).
| Genotype | Body Weight (g) | Lean Mass (g) | Fat Mass (g) | % Fat | % Lean | VO2 (ml/kg/hr) | VCO2 (ml/kg/hr) | EE (kcal/hr) | Horizontal Activity (counts/min) | Ambulatory Activity (counts/min) | Vertical Activity (counts/min) | Treadmill EE (kcal/hr) | Treadmill RER | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Resting EE | Total activity EE | Activity EE-resting EE | Last 90 min of rest | Total 30 min of activity | ||||||||||||
| 339.55*,† (8.77) | 223.63*,† (5.56) | 65.48*,† (3.86) | 20.04*,† (0.78) | 68.80*,† (0.79) | 1588*,† (16.44) | 1580 (21.36) | 2.72*,† (0.07) | 5.01*,† (0.21) | 2.31* (0.13) | 0.21*,† (0.02) | 2.37 (0.06) | 5.67 (0.29) | 3.30 (0.27) | 0.87 (0.01) | 0.90 (0.01) | |
| 245.24 (7.78) | 183.51 (3.16) | 25.82 (1.52) | 10.77 (0.64) | 76.53 (1.07) | 1743 (26.85) | 1671 (32.79) | 2.14 (0.04) | 6.12 (0.26) | 2.68 (0.13) | 0.35 (0.02) | 1.93 (0.05) | 4.52 (0.16) | 2.59 (0.17) | 0.87 (0.82) | 0.90 (0.01) | |
| 244.88 (8.31) | 183.88 (6.36) | 24.86 (1.28) | 10.67 (0.51) | 78.72 (0.34) | 1684 (31.15) | 1679 (42.12) | 2.14 (0.06) | 6.72 (0.16) | 2.98 (0.11) | 0.36 (0.02) | 1.97 (0.14) | 4.57 (0.18) | 2.60 (0.23) | 0.82 (0.02) | 0.87 (0.01) | |
Male rats homozygous (Mc4r, n = 8) or heterozygous (Mc4r+, n = 8) for non-functional melanocortin 4 receptor (MC4R), or wild-type rats (Mc4r+, n = 6). RER, respiratory exchange ratio (VCO2/VO2).
*significantly different from Mc4r+; †significantly different from Mc4r+; p < 0.05.
Figure 1Effects of Mc4r mutation on energy expenditure, physical activity, body composition, and food intake in male rats.
(A) When body weight is taken into account using covariance, no difference is seen between genotypes in energy expenditure. (B) Respiratory exchange ratio (RER, VCO2/VO2), an indicator of substrate use, was significantly higher in rats lacking functional MC4R (Mc4r) compared to wild-type (Mc4r+) rats or rats heterozygous for the allele (Mc4r+) during 24-hr calorimetry. (C) During the first 10 min of controlled treadmill activity after short-term food restriction, RER of Mc4r rats was higher than Mc4r+ rats’ RER, indicating a lower reliance on lipids compared to Mc4r+ rats. Over the course of 12 days in activity monitors, Mc4r rats (n = 8) showed consistently suppressed physical activity, including (D) distance traveled, (E) time spent resting, (F) stereotypic movements (e.g., grooming), and (G) vertical movements (e.g., rearing). (H) Mc4r rats were significantly heavier than either Mc4r+ (n = 8) or Mc4r+ rats (n = 8), primarily because of fat mass. (I) While Mc4r+ and Mc4r+ rats did not differ in body weight, Mc4r+ rats had a moderately but significantly greater fat-to-lean ratio. (J) Mc4r rats showed greater daily energy intake; Mc4r+ and Mc4r+ rats did not differ from each other in food intake. *significantly different from Mc4r+; †significantly different from Mc4r+; p < 0.05. For all calorimetry, n = 8 Mc4r, n = 8 Mc4r+, n = 6 Mc4r+; For all other measures, n = 8 Mc4r, n = 8 Mc4r+, n = 8 Mc4r+.
Long-term activity measurements; Mean (SEM).
| Genotype | BW (g) | Food Intake (g) | Water intake (ml) | Ambulatory Time (sec/min) | Bursts of stereotypic activity (per min) | Horizontal counts (per min) | Ambulatory counts (per min) | Bursts of vertical activity (per min) | CW rotations (per min) | CCW rotations (per min) | Fat mass (g) | Lean mass (g) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 509.53*,† (10.99) | 34.61*,† (1.38) | 47.41*,† (2.45) | 2.72† (0.1) | 2.75*,† ±0.05 | 16.46*,† (0.95) | 9.10*,† (0.68) | 0.03 (0.01) | 0.27*,† (0.01) | 0.26*,† (0.01) | 191.07*,† (6.23) | 355.49† (10.11) | |
| 361.13 (12.10) | 24.69 (2.15) | 36.98 (1.69) | 3.34 (0.11) | 3.45 ±0.08 | 23.22 (0.94) | 12.83 (0.65) | 0.05 (0.01) | 0.35 (0.01) | 0.35 (0.01) | 67.98 (6.34) | 323.2 (5.74) | |
| 360.88 (15.59) | 23.44 (1.54) | 35.17 (1.98) | 3.04 (0.17) | 3.36 ±0.09 | 24.32 (0.66) | 13.49 (0.56) | 0.06 (0.01) | 0.32 (0.02) | 0.32 (0.02) | 56.16 (2.04) | 337.31 (6.31) |
Male rats homozygous (Mc4r, n = 8) or heterozygous (Mc4r+, n = 8) for non-functional melanocortin 4 receptor (MC4R), or wild-type rats (Mc4r+, n = 8).
CW: clockwise; CCW: counter-clockwise.
*significantly different from Mc4r+; †significantly different from Mc4r+; p < 0.05.
Figure 2Weight loss during 50% food restriction in male rats homozygous (Mc4r) or heterozygous (Mc4r+) for the non-functional melanocortin 4 receptor (MC4R), compared to wild-type rats (Mc4r+).
(A) Mc4r+ rats lost more weight compared to Mc4r+ rats; these groups did not show differences in baseline food intake or body weight. (B) The relative loss of fat mass differed according to genotype, where most of the weight lost in Mc4r was from fat mass, and nearly half of the weight lost in Mc4r+ was from lean mass. N = 8/group. *significantly different from Mc4r+; †significantly different from Mc4r+; p < 0.05.
Body weight and composition in male rats before and after 21 days of 50% calorie restriction (CR), and after 14 days of ad libitum recovery from CR; Mean (SEM).
| Genotype | Baseline | Calorie restriction | CR-induced change | ||||||
|---|---|---|---|---|---|---|---|---|---|
| BW (g) | Fat mass (g) | Lean mass (g) | BW (g) | Fat mass (g) | Lean mass (g) | Fat mass (g) | Lean mass (g) | % BW lost | |
| 705.46*,† (22.25) | 263.50*,† (10.06) | 389.68*,† (13.31) | 629.66*,† (17.62) | 198.49* (6.53) | 364.38*,† (11.69) | −65.01*,† (5.61) | −25.31*,† (2.27) | −10.67*,† (0.46) | |
| 505.16 (11.70) | 103.37* (7.26) | 353.32 (5.12) | 431.34 (12.54) | 51.40* (5.64) | 319.66 (7.20) | −51.98 (2.10) | −33.66* (2.87) | −14.96* (0.57) | |
| 500.68 (9.79) | 80.78 (2.27) | 368.45 (7.44) | 415.34 (9.16) | 33.98 (1.77) | 320.21 (6.59) | −46.80 (1.79) | −48.24 (2.21) | −17.06 (0.62) | |
| Ad libitum-fed recovery from CR | Recovery-induced increase from CR | Recovery-induced increase relative to baseline | |||||||
| BW (g) | Fat mass (g) | Lean mass (g) | Increase in BW (g) | Increase in fat mass (g) | Increase in lean mass (g) | Change in BW (g) | Change in fat (g) | Change in lean mass (g) | |
| 708.04*,† (21.56) | 233.41*,† (8.01) | 401.35*,† (14.65) | 78.39 (4.81) | 34.93 (2.78) | 36.98* (3.22) | 2.59 (3.86) | −30.08*,† (3.26) | 11.67* (3.01) | |
| 509.11 (12.26) | 84.23* (6.31) | 359.94 (6.39) | 77.76 (3.28) | 32.84 (1.76) | 40.27 (2.45) | 3.95 (3.31) | −19.14 (2.08) | 6.61 (2.16) | |
| 498.68 (8.13) | 62.86 (1.91) | 368.46 (7.44) | 83.33 (3.29) | 28.89 (1.83) | 48.26 (2.64) | −2.00 (4.09) | −17.92 (2.86) | 0.02 (1.97) | |
Male rats homozygous (Mc4r, n = 8) or heterozygous (Mc4r+, n = 8) for non-functional melanocortin 4 receptor (MC4R), or wild-type rats (Mc4r+, n = 8).
BW: Body weight.
*significantly different from Mc4r+; †significantly different from Mc4r+; p < 0.05.
Regional mRNA expression of melanocortin receptors 3 (MC3R) and 5 (MC5R), percent expression relative to Mc4r+ (100%); circulating and adipose cytokines, Mean (SEM).
| Genotype | ARC | PVN | PeFLH | VMH | DMH | Cytokine (pg/ml) | WAT | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MC3R | MC5R | MC3R | MC5R | BDNF | MC3R | MC5R | MC3R | MC5R | BDNF | MC3R | MC5R | Leptin | IL-1α | IL-1β | IL-6 | IL-10 | TNF-α | TNF-α | |
| 158 (32) | 101 (7) | 109*,† (2) | 108 (3) | 102† (3) | 104 (2) | 102 (5) | 149 (8) | 97 (7) | 120 (9) | 129 (11) | 125 (14) | 11962.00*,† (808.26) | 44.58 (6.65) | 387.85 (89.10) | 33.76 (2.14) | 293.89 (84.58) | 25.79 (2.90) | 349 (29) | |
| 112 (4) | 98 (9) | 96 (3) | 94 (4) | 91* (3) | 156 (7) | 115 (7) | 131 (14) | 96 (3) | 108 (7) | 122 (14) | 132 (12) | 9843.50 (541.98) | 37.31 (2.00) | 205.99 (34.16) | 35.36 (2.82) | 170.06 (30.88) | 23.14 (0.64) | 383 (48) | |
| 100 (3) | 100 (6) | 100 (4) | 100 (4) | 100 (1) | 100 (6) | 100 (1) | 100 (12) | 100 (10) | 100 (7) | 100 (5) | 100 (5) | 9425.75 (534.51) | 43.40 (6.30) | 370.06 (92.45) | 34.73 (3.33) | 257.50 (66.48) | 26.06 (1.75) | 537 (195) | |
Rats homozygous (Mc4r, n = 5) or heterozygous (Mc4r+, n = 6) for non-functional melanocortin 4 receptor (MC4R), or wild-type rats (Mc4r+, n = 4).
ARC: arcuate nucleus; PVN: paraventricular nucleus; PeFLH: perifornical lateral hypothalamus; VMH: ventromedial hypothalamus; DMH: dorsomedial hypothalamus; WAT: epididymal white adipose tissue. Cytokines (n = 8/group) interleukins (IL) 1α, 1β, 6, and 10, and tumor necrosis factor- α (TNF- α).
*significantly different from Mc4r+; †significantly different from Mc4r+; p < 0.05.